301. Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation.
- Author
-
Zhang D, Wang Y, Shi Z, Liu J, Sun P, Hou X, Zhang J, Zhao S, Zhou BP, and Mi J
- Subjects
- Animals, Cells, Cultured, Colonic Neoplasms metabolism, Electron Transport Complex I metabolism, Fibroblasts cytology, Fibroblasts drug effects, Glucose metabolism, Glycolysis drug effects, Humans, Hypoxia-Inducible Factor 1, alpha Subunit metabolism, Isocitrate Dehydrogenase antagonists & inhibitors, Isocitrate Dehydrogenase genetics, Ketoglutaric Acids metabolism, Mice, Mice, Inbred BALB C, Mice, Nude, MicroRNAs metabolism, Oxidative Phosphorylation, Phosphorylation, Platelet-Derived Growth Factor pharmacology, Prolyl Hydroxylases metabolism, RNA, Small Interfering metabolism, Transforming Growth Factor beta1 pharmacology, Up-Regulation drug effects, Colonic Neoplasms pathology, Down-Regulation drug effects, Fibroblasts metabolism, Isocitrate Dehydrogenase metabolism, Metabolic Engineering
- Abstract
Cancer-associated fibroblasts (CAFs) provide critical metabolites for tumor growth and undergo metabolic reprogramming to support glycolysis. However, the molecular mechanisms responsible for this change remain unclear. Here, we report that TGF-β1- or PDGF-induced CAFs switch from oxidative phosphorylation to aerobic glycolysis. We identify downregulation of isocitrate dehydrogenase 3α (IDH3α) as a marker for this switch. Furthermore, miR-424 downregulates IDH3α during CAF formation. Downregulation of IDH3α decreases the effective level of α-ketoglutarate (α-KG) by reducing the ratio of α-KG to fumarate and succinate, resulting in PHD2 inhibition and HIF-1α protein stabilization. The accumulation of HIF-1α, in turn, promotes glycolysis by increasing the uptake of glucose, upregulating expression of glycolytic enzymes under normoxic conditions, and inhibiting oxidative phosphorylation by upregulating NDUFA4L2. CAFs from tumor samples exhibit low levels of IDH3α, and overexpression of IDH3α prevents transformation of fibroblasts into CAFs. Our studies reveal IDH3α to be a critical metabolic switch in CAFs., (Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF